280 related articles for article (PubMed ID: 26555092)
1. Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case.
Belinsky MG; Rink L; Cai KQ; Capuzzi SJ; Hoang Y; Chien J; Godwin AK; von Mehren M
BMC Cancer; 2015 Nov; 15():887. PubMed ID: 26555092
[TBL] [Abstract][Full Text] [Related]
2. Succinate dehydrogenase deficiency in a PDGFRA mutated GIST.
Belinsky MG; Cai KQ; Zhou Y; Luo B; Pei J; Rink L; von Mehren M
BMC Cancer; 2017 Aug; 17(1):512. PubMed ID: 28768491
[TBL] [Abstract][Full Text] [Related]
3. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
Boikos SA; Pappo AS; Killian JK; LaQuaglia MP; Weldon CB; George S; Trent JC; von Mehren M; Wright JA; Schiffman JD; Raygada M; Pacak K; Meltzer PS; Miettinen MM; Stratakis C; Janeway KA; Helman LJ
JAMA Oncol; 2016 Jul; 2(7):922-8. PubMed ID: 27011036
[TBL] [Abstract][Full Text] [Related]
4. SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors.
Italiano A; Chen CL; Sung YS; Singer S; DeMatteo RP; LaQuaglia MP; Besmer P; Socci N; Antonescu CR
BMC Cancer; 2012 Sep; 12():408. PubMed ID: 22974104
[TBL] [Abstract][Full Text] [Related]
5. MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation.
Schaefer IM; Wang Y; Liang CW; Bahri N; Quattrone A; Doyle L; Mariño-Enríquez A; Lauria A; Zhu M; Debiec-Rychter M; Grunewald S; Hechtman JF; Dufresne A; Antonescu CR; Beadling C; Sicinska ET; van de Rijn M; Demetri GD; Ladanyi M; Corless CL; Heinrich MC; Raut CP; Bauer S; Fletcher JA
Nat Commun; 2017 Mar; 8():14674. PubMed ID: 28270683
[TBL] [Abstract][Full Text] [Related]
6. Classification of gastrointestinal stromal tumor syndromes.
Gopie P; Mei L; Faber AC; Grossman SR; Smith SC; Boikos SA
Endocr Relat Cancer; 2018 Feb; 25(2):R49-R58. PubMed ID: 29170162
[TBL] [Abstract][Full Text] [Related]
7. Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction.
Nannini M; Astolfi A; Paterini P; Urbini M; Santini D; Catena F; Indio V; Casadio R; Pinna AD; Biasco G; Pantaleo MA
Future Oncol; 2013 Jan; 9(1):121-6. PubMed ID: 23252569
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients.
Maertens O; Prenen H; Debiec-Rychter M; Wozniak A; Sciot R; Pauwels P; De Wever I; Vermeesch JR; de Raedt T; De Paepe A; Speleman F; van Oosterom A; Messiaen L; Legius E
Hum Mol Genet; 2006 Mar; 15(6):1015-23. PubMed ID: 16461335
[TBL] [Abstract][Full Text] [Related]
9. Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.
Huss S; Elges S; Trautmann M; Sperveslage J; Hartmann W; Wardelmann E
Expert Rev Anticancer Ther; 2015 Jun; 15(6):623-8. PubMed ID: 25831232
[TBL] [Abstract][Full Text] [Related]
10. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.
Janeway KA; Kim SY; Lodish M; Nosé V; Rustin P; Gaal J; Dahia PL; Liegl B; Ball ER; Raygada M; Lai AH; Kelly L; Hornick JL; ; O'Sullivan M; de Krijger RR; Dinjens WN; Demetri GD; Antonescu CR; Fletcher JA; Helman L; Stratakis CA
Proc Natl Acad Sci U S A; 2011 Jan; 108(1):314-8. PubMed ID: 21173220
[TBL] [Abstract][Full Text] [Related]
11. Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.
Pantaleo MA; Astolfi A; Urbini M; Nannini M; Paterini P; Indio V; Saponara M; Formica S; Ceccarelli C; Casadio R; Rossi G; Bertolini F; Santini D; Pirini MG; Fiorentino M; Basso U; Biasco G;
Eur J Hum Genet; 2014 Jan; 22(1):32-9. PubMed ID: 23612575
[TBL] [Abstract][Full Text] [Related]
12. Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1.
Stewart DR; Corless CL; Rubin BP; Heinrich MC; Messiaen LM; Kessler LJ; Zhang PJ; Brooks DG
J Med Genet; 2007 Jan; 44(1):e61. PubMed ID: 17209131
[TBL] [Abstract][Full Text] [Related]
13. Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.
Gasparotto D; Rossi S; Polano M; Tamborini E; Lorenzetto E; Sbaraglia M; Mondello A; Massani M; Lamon S; Bracci R; Mandolesi A; Frate E; Stanzial F; Agaj J; Mazzoleni G; Pilotti S; Gronchi A; Dei Tos AP; Maestro R
Clin Cancer Res; 2017 Jan; 23(1):273-282. PubMed ID: 27390349
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.
Belinsky MG; Rink L; Flieder DB; Jahromi MS; Schiffman JD; Godwin AK; von Mehren M
Genes Chromosomes Cancer; 2013 Feb; 52(2):214-24. PubMed ID: 23109135
[TBL] [Abstract][Full Text] [Related]
15. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.
Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA
Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012
[TBL] [Abstract][Full Text] [Related]
16. A Duodenal SDH-Deficient Gastrointestinal Stromal Tumor in a Patient With a Germline SDHB Mutation.
Elston MS; Sehgal S; Dray M; Phillips E; Conaglen JV; Clifton-Bligh RJ; Gill AJ
J Clin Endocrinol Metab; 2017 May; 102(5):1447-1450. PubMed ID: 28324028
[TBL] [Abstract][Full Text] [Related]
17. SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing.
Pantaleo MA; Astolfi A; Indio V; Moore R; Thiessen N; Heinrich MC; Gnocchi C; Santini D; Catena F; Formica S; Martelli PL; Casadio R; Pession A; Biasco G
J Natl Cancer Inst; 2011 Jun; 103(12):983-7. PubMed ID: 21505157
[TBL] [Abstract][Full Text] [Related]
18. Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).
Nannini M; Astolfi A; Urbini M; Indio V; Santini D; Heinrich MC; Corless CL; Ceccarelli C; Saponara M; Mandrioli A; Lolli C; Ercolani G; Brandi G; Biasco G; Pantaleo MA
BMC Cancer; 2014 Sep; 14():685. PubMed ID: 25239601
[TBL] [Abstract][Full Text] [Related]
19. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.
Agaimy A; Terracciano LM; Dirnhofer S; Tornillo L; Foerster A; Hartmann A; Bihl MP
J Clin Pathol; 2009 Jul; 62(7):613-6. PubMed ID: 19561230
[TBL] [Abstract][Full Text] [Related]
20. Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom two-gene targeted next-generation sequencing panel with therapeutic intent.
Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
Gastrointest Endosc; 2016 Dec; 84(6):950-958.e3. PubMed ID: 27118626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
